Evidence map›Paper›PMID 35127106›Full record

ArticleCanadian journal of kidney health and disease2022

Designing an App for Immunosuppression Adherence and Communication: A Qualitative Approach.

Kara Schick-Makaroff, Laura Lagendyk, Bethany Foster, Ngan N Lam, Branko Braam, Aminu Bello, Soroush Shojai, Kevin Wen

Open access · goldAbstract read
In one paragraph

Article in Canadian journal of kidney health and disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kara Schick-MakaroffUniversity of Alberta, Edmonton, Canada.ORCID https://orcid.org/0000-0001-6200-3416
Laura LagendykQuotesWork, Turner Valley, AB, Canada.
Bethany FosterDepartment of Pediatrics, Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.
Ngan N LamDivision of Nephrology, Cumming School of Medicine, University of Calgary, AB, Canada.ORCID https://orcid.org/0000-0002-0129-7091
Branko BraamDivision of Nephrology and Transplant Immunology, Department of Medicine, University of Alberta, Edmonton, Canada.
Aminu BelloDivision of Nephrology and Transplant Immunology, Department of Medicine, University of Alberta, Edmonton, Canada.
Soroush ShojaiDivision of Nephrology and Transplant Immunology, Department of Medicine, University of Alberta, Edmonton, Canada.
Kevin WenDivision of Nephrology and Transplant Immunology, Department of Medicine, University of Alberta, Edmonton, Canada.
University of Alberta · CAMcGill University Health Centre · CAUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImmunosuppression nonadherence may be the most important factor limiting long-term allograft survival.

objectiveFollowing user-centered design, we explored the essential priorities and preferences of kidney transplant recipients and healthcare providers (HCP) to inform development of a smartphone app to improve immunosuppression adherence and communication.

designA qualitative descriptive research design was used.

settingThe University of Alberta Hospital adult kidney transplant program in Edmonton, Canada.

participantsParticipants were recruited by convenience sampling and included 32 kidney transplant recipients and 11 HCPs.

methodsSeven focus groups (5 with recipients and 2 with HCPs) were conducted to inform app development. Sessions were recorded, and transcripts were coded to elucidate themes.

resultsApp development to improve adherence was not a priority for HCP. Recipients prioritized choice: that all features be optional. Recipients preferred support while traveling; access to laboratory results; and use by younger or newly transplanted recipients. Both recipients and HCP preferred linkage to pharmacy; and self-management and accountability.For the app to improve communication, HCPs believed the priorities to be addressed included: clarity on scope of app; legal, ethical, and professional obligations; and charting. Both recipients and HCP prioritized HCP workload, and broader medication and health concerns. Healthcare providers preferred tech support; both recipients and HCPs preferred app access for nontransplant HCP. LIMITATIONS: Limitations include underrepresentation of physicians, recipients with racial/ethnic diversity, and potential selection bias of transplant recipients who perceived themselves to be adhering to immunosuppression medications.

conclusionFuture research is needed for the app to become a comprehensive, secure platform for broader communication between recipients and HCP, pharmacies, and nontransplant clinicians while streamlining HCP workload.

Indexed as

communicationeHealthimmunosuppressionmobile healthtransplantation

Identifiers

PMID35127106
PMCPMC8808030
OpenAlexW4210767839

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.